These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9351838)

  • 1. Intramolecular synapsis of duplex DNA by vaccinia topoisomerase.
    Shuman S; Bear DG; Sekiguchi J
    EMBO J; 1997 Nov; 16(21):6584-9. PubMed ID: 9351838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atomic force microscopy shows that vaccinia topoisomerase IB generates filaments on DNA in a cooperative fashion.
    Moreno-Herrero F; Holtzer L; Koster DA; Shuman S; Dekker C; Dekker NH
    Nucleic Acids Res; 2005; 33(18):5945-53. PubMed ID: 16237128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of 26 residues of vaccinia DNA topoisomerase identifies Ser-204 as important for DNA binding and cleavage.
    Wang LK; Wittschieben J; Shuman S
    Biochemistry; 1997 Jul; 36(26):7944-50. PubMed ID: 9201940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribonuclease activity of vaccinia DNA topoisomerase IB: kinetic and high-throughput inhibition studies using a robust continuous fluorescence assay.
    Kwon K; Nagarajan R; Stivers JT
    Biochemistry; 2004 Nov; 43(47):14994-5004. PubMed ID: 15554707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccinia virus DNA topoisomerase I preferentially removes positive supercoils from DNA.
    Fernandez-Beros ME; Tse-Dinh YC
    FEBS Lett; 1996 Apr; 384(3):265-8. PubMed ID: 8617368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolone-dependent DNA supercoiling by Vaccinia topoisomerase I.
    Kamau E; Grove A
    J Mol Biol; 2004 Sep; 342(2):479-87. PubMed ID: 15327948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p-Thiophenylalanine-induced DNA cleavage and religation activity of a modified vaccinia topoisomerase IB.
    Chen S; Zhang Y; Hecht SM
    Biochemistry; 2011 Nov; 50(43):9340-51. PubMed ID: 21942719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirements for noncovalent binding of vaccinia topoisomerase I to duplex DNA.
    Sekiguchi J; Shuman S
    Nucleic Acids Res; 1994 Dec; 22(24):5360-5. PubMed ID: 7816626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical and traditional mutagenesis of vaccinia DNA topoisomerase provides insights to cleavage site recognition and transesterification chemistry.
    Yakovleva L; Chen S; Hecht SM; Shuman S
    J Biol Chem; 2008 Jun; 283(23):16093-103. PubMed ID: 18367446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An engineered mutant of vaccinia virus DNA topoisomerase I is sensitive to the anti-cancer drug camptothecin.
    Gupta M; Zhu CX; Tse-Dinh YC
    J Biol Chem; 1992 Dec; 267(34):24177-80. PubMed ID: 1332948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of DNA Binding by the Isolated N-Terminal Domain of Vaccinia Virus DNA Topoisomerase IB.
    Reed B; Yakovleva L; Shuman S; Ghose R
    Biochemistry; 2017 Jul; 56(26):3307-3317. PubMed ID: 28570045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A catalytic domain of eukaryotic DNA topoisomerase I.
    Cheng C; Shuman S
    J Biol Chem; 1998 May; 273(19):11589-95. PubMed ID: 9565576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement of the active site tyrosine of vaccinia DNA topoisomerase by glutamate, cysteine or histidine converts the enzyme into a site-specific endonuclease.
    Wittschieben J; Petersen BO; Shuman S
    Nucleic Acids Res; 1998 Jan; 26(2):490-6. PubMed ID: 9421505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction in vitro of type III intermediate filament proteins with supercoiled plasmid DNA and modulation of eukaryotic DNA topoisomerase I and II activities.
    Li G; Tolstonog GV; Sabasch M; Traub P
    DNA Cell Biol; 2002 Oct; 21(10):743-69. PubMed ID: 12443544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA supercoiling and topoisomerases in Escherichia coli].
    Gómez-Eichelmann MC; Camacho-Carranza R
    Rev Latinoam Microbiol; 1995; 37(3):291-304. PubMed ID: 8850348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletions at the carboxyl terminus of vaccinia DNA topoisomerase affect DNA binding and enhance distributivity in DNA relaxation.
    Wang LK; Shuman S
    Biochemistry; 1997 Apr; 36(13):3909-16. PubMed ID: 9092821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccinia DNA topoisomerase I: evidence supporting a free rotation mechanism for DNA supercoil relaxation.
    Stivers JT; Harris TK; Mildvan AS
    Biochemistry; 1997 Apr; 36(17):5212-22. PubMed ID: 9136883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent and noncovalent DNA binding by mutants of vaccinia DNA topoisomerase I.
    Morham SG; Shuman S
    J Biol Chem; 1992 Aug; 267(22):15984-92. PubMed ID: 1322412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombination mediated by vaccinia virus DNA topoisomerase I in Escherichia coli is sequence specific.
    Shuman S
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10104-8. PubMed ID: 1658796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A vaccinia virus DNase preparation which cross-links superhelical DNA.
    Lakritz N; Foglesong PD; Reddy M; Baum S; Hurwitz J; Bauer WR
    J Virol; 1985 Mar; 53(3):935-43. PubMed ID: 3871865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.